Pharmaceutical composition containing sibutramine and orlistat
CA 2315259 A1 · Owner: Abbott Gmbh & Co. Kg · Inventors: Heal, David John; Jackson, Helen Christine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for the treatment of obesity in a human in need of such treatment which comprises administration to the human of therapeutically effective amount of a compound of formula (I) including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl and a therapeutically effective amount of a compound of formula (II) wherein the compound of formula (I) and the compound of formula (II) are administered simultaneously, separately or sequentially.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 16, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 16, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 16, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.